Narlumosbart Antibody

SKU: orb1944137

Description

Narlumosbart (JMT103) is a human IgG4κ monoclonal antibody designed to specifically target RANKL. It is utilized in research to investigate bone metabolism disorders, including osteoporosis and bone metastasis, through both in vitro binding assays and in vivo preclinical models.

Research Area

Signal Transduction

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Target	RANKL/RANK
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

RANKL/RANK

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols